16
1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T77434 | Vopratelimab | JTX 2011 | Others |
Vopratelimab (JTX-2011) is a selective humanized immunoglobulin G1-kappa monoclonal antibody that is a potent ICOS agonist. Vopratelimab has a high affinity for inducible T cell CO stimulating factors (ICOS), with an aff... | |||
T82901 | Belrestotug | GSK4428859A,EOS884448,EOS-448 | |
Belrestotug (EOS-448), an antagonistic anti-TIGIT (VSIG9, VSTM3) antibody of the human immunoglobulin G1 kappa (hIgG1 kappa) class, exhibits antineoplastic activity [1]. | |||
T82419 | Falbikitug | ||
Falbikitug is a humanized immunoglobulin G1-kappa monoclonal antibody targeting LIF, with antineoplastic properties [1]. | |||
T78285 | Sofituzumab | MMUC 1206A | |
Sofituzumab (MMUC 1206A) is a humanized monoclonal antibody targeting the MUC16 antigen, specifically the recombinant V-kappa immunoglobulin variant [1]. | |||
T81313 | Raludotatug | ||
Raludotatug is a humanized immunoglobulin G1-kappa monoclonal antibody targeting CDH6, with antineoplastic properties. | |||
T80855 | Vonsetamig | ||
Vonsetamig, a humanized immunoglobulin G4-kappa monoclonal antibody, targets both TNFRSF17 and CD3E. It serves as an antineoplastic agent. | |||
T82490 | Eglatoprutug | ||
Eglatoprutug is a humanized immunoglobulin G1-kappa monoclonal antibody targeting the c-Kit receptor [1]. | |||
T81610 | Oloctinebart | ||
Oloctinebart, a humanized immunoglobulin G4-kappa (IgG4-κ) monoclonal antibody targeting LGALS3, is utilized to decrease the formation of amyloid beta oligomers [1]. | |||
T81124 | Sovipostobart | ||
Sovipostobart, an immunoglobulin G1-kappa monoclonal antibody targeting CTLA-4 in Homo sapiens, features a cleavable prodomain. This compound serves as both an immunostimulant and antineoplastic [1]. | |||
T81538 | Patecibart | Endothelin Receptor | |
Patecibart is a humanized immunoglobulin G4-kappa monoclonal antibody that functions as an antagonist to the endothelin receptor A (EDNRA). | |||
T78292 | Ifinatamab | Anti-Human B7-H3 | |
Ifinatamab is a monoclonal immunoglobulin G1-kappa antibody that targets the human B7-H3 protein (B7 homolog 3). It functions as a glycoform α immunomodulator [1]. | |||
T22856 | IgG light chain variable region [Homo sapiens]/IgM/kappa antibody [Mus musculus] | Others | |
IgG has four forms, provides the majority of antibody-based immunity against invading pathogens. The only antibody capable of crossing the placenta to give passive immunity to the fetus. Eliminates pathogens in the early... | |||
T82076 | Imbotolimod | ||
Imbotolimod, a humanized monoclonal antibody of the immunoglobulin G1-kappa class, exhibits both anti-ERBB2 and antineoplastic activities. It is a derivative of telratolimod [1]. | |||
T77000 | Cirevetmab | ||
Cirevetmab (ZTS-00521426), a caninized monoclonal antibody targeting Canis lupus familiaris TGFB1, is classified as an immunoglobulin G2-kappa. It functions as an immunomodulator [1]. | |||
T78322 | Lesabelimab | LDP | |
Lesabelimab (LDP) is an anti-CD274 monoclonal antibody of the immunoglobulin G1-kappa subclass. It targets CD274, an immune checkpoint ligand that suppresses antitumor immunity by engaging with the PDCD1 receptor [1] [2]... | |||
T76950 | Zansecimab | ||
Zansecimab (LY-3127804), an immunoglobulin G4-kappa monoclonal antibody targeting angiopoietin 2 (Ang 2), exhibits potential in angiogenesis and immune regulation [1] [2] [3]. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-00748 | Ig kappa Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Immunoglobulin Kappa is constant region of immunoglobulin light chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humor... |